US “executive screening programmes” offer expensive cardiovascular testing even though the tests are not justified and often not covered by insurance, according to a report published in JAMA Internal Medicine.1
Leading US medical centres offer “executive screening” at prices ranging from $995 (£760; €901) to $25 000 to wealthy people who can pay out of pocket for tests not covered by insurance. Professional organisations usually do not recommend the tests for asymptomatic people and there is no evidence they reduce deaths from heart disease.
Not only is this bad medicine but …

中文翻译：

---

军医说，美国行政人员心脏筛查计划违反了“请勿伤害”规则。

根据《美国医学会杂志》内部医学杂志（JAMA Internal Medicine）发表的一份报告，即使检查不合理且通常不在保险范围内，美国的“执行筛查程序”也提供昂贵的心血管检查。1
美国领先的医疗中心向有钱者提供“执行性检查”，价格从995美元（760英镑； 901欧元）到25,000美元不等，他们可以自掏腰包支付保险未涵盖的检查费用。专业组织通常不建议对无症状者进行检查，也没有证据表明它们可以减少因心脏病死亡的人数。
这不仅是不好的药，而且…